Last $4.56 USD
Change Today +0.04 / 0.88%
Volume 62.2K
CPIX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

A. J. Kazimi MBA

Founder, Chairman, Chief Executive Officer and President, Cumberland Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 58 board members in 4 different organizations across 3 different industries.

See Board Relationships
56$861,450
As of Fiscal Year 2013

Background*

Mr. A. J. Kazimi, MBA founded Cumberland Pharmaceuticals Inc. in 1999 and has been its Chairman and Chief Executive Officer since 1999. Mr. Kazimi serves as the President of Cumberland Pharmaceuticals, Inc. and served as its Principal Financial Officer since April 4, 2011. He is the Founder of Cumberland Emerging Technologies, a subsidiary of Cumberland Pharmaceuticals Inc. and serves as its Chief Executive Officer. He has 20 years career in the biopharmaceutical industry. ...

Read Full Background

Corporate Headquarters*

2525 West End Avenue
Nashville, Tennessee 37203

United States

Phone: 615-255-0068
Fax: 615-255-0094

Board Members Memberships*

Director
Director
Founder, Chairman, Chief Executive Officer and President
Director
1994-N/A
Former President, Chief Operating Officer and Director

Education*

Bachelor's Degree
University of Notre Dame
BS
University of Notre Dame
MBA
Owen School of Management, Vanderbilt University
Unknown/Other Education
School of Medicine, Vanderbilt University

Other Affiliations*

Annual Compensation*

Salary$435,000
Bonus$185,000
Total Annual Compensation$620,000

Stock Options*

Restricted Stock Awards$239,000
All Other Compensation$2,450

Total Compensation*

Total Annual Cash Compensation$622,450
Total Short Term Compensation$620,000
Other Long Term Compensation$241,450
Total Calculated Compensation$861,450
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CPIX:US $4.56 USD +0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Arthur P. Bedrosian J.D.Chief Executive Officer, President, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$437.5K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CUMBERLAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.